Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 -0.02 (-0.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Operating Expenses (2018 - 2026)

Updated

Fulcrum Therapeutics' Operating Expenses was $29.31 million in Q2 2026, up 47.9% from $19.82 million a year earlier and up 32.1% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Operating Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Fulcrum Therapeutics' Operating Expenses was $96.05 million through Jun 30, 2026, up 13.3% year-over-year; for FY2025, it came in at $84.77 million, down 16.8% from FY2024.

  • Operating Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $101.9 million in FY2024 (-10.2%), $113.47 million in FY2023 (-4.6%), $118.9 million in FY2022 (+18.6%) and $100.22 million in FY2021 (+24.6%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses since Q1 2024.
  • Compared with a year earlier, Operating Expenses has increased for three straight quarters, with an average decline of 5.3% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q2 2022 (growth of 50.1%); the worst was Q4 2024 (a decline of 32.7%).
  • Per Business Quant data, FULC's Operating Expenses in the three quarters before Q2 2026 was $22.19 million (Q1 2026), $22.69 million (Q4 2025) and $21.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Fulcrum Therapeutics 283.78 Mn 283.78 Mn - 29.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.31 Mn
Mar 31, 2026 22.19 Mn
Dec 31, 2025 22.69 Mn
Sep 30, 2025 21.86 Mn
Jun 30, 2025 19.82 Mn
Mar 31, 2025 20.40 Mn
Dec 31, 2024 19.43 Mn
Sep 30, 2024 25.13 Mn
Jun 30, 2024 27.51 Mn
Mar 31, 2024 29.83 Mn
Dec 31, 2023 28.86 Mn
Sep 30, 2023 28.20 Mn
Jun 30, 2023 28.17 Mn
Mar 31, 2023 28.24 Mn
Dec 31, 2022 28.66 Mn
Sep 30, 2022 25.54 Mn
Jun 30, 2022 36.12 Mn
Mar 31, 2022 28.59 Mn
Dec 31, 2021 28.62 Mn
Sep 30, 2021 25.71 Mn
API Access

Fulcrum Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=FULC&period=max&api_key=YOUR_API_KEY